Multiple sclerosis is an autoimmune condition that affects your central nervous system. The condition causes your immune system to attack the myelin cells, the protective sheaths surrounding your ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

UK researchers have unveiled an innovative artificial intelligence (AI) tool, named MindGlide, designed to interpret and ...

The fatigue and lack of motivation that many cancer patients experience near the end of life have been seen as the ...

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

Stephen Hauser and Alberto Ascherio were awarded the prestigious Breakthrough Prize on Sunday for their groundbreaking ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...

Roche’s phase III MUSETTE trial of Ocrevus high dose in people with relapsing multiple sclerosis fails to meet primary endpoint: Basel Friday, April 4, 2025, 11:00 Hrs [IST] Roc ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...

Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s ...

it has excellent potential to treat Parkinson’s disease as well as various Parkinsonian disorders such as Multiple System Atrophy (MSA). ATH434 successfully completed Phase 1 studies demonstrating the ...

The discoveries were made ... Epstein-Barr Virus and Brain Cross-Reactivity: Possible Mechanism for Multiple Sclerosis June 6, 2024 — The role that Epstein-Barr Virus (EBV) plays in the ...